The surrogacy tourism market is estimated at US$ 258.8 million in 2023 and is projected to reach US$ 468.9 million by 2033, at a CAGR of 6.1% from 2023 to 2033. Total sales of surrogacy tourism represent 2-3% of the market.
Gestational surrogacy dominated the tourism market by type and is expected to continue this trend throughout the forecast period, owing to surrogacy professionals' high adoption of gestational techniques and technological advancements.
Major Indicators Creating a Buzz about Surrogacy Tourism
Expensive fertility treatment, unsuccessful infertility treatment, ban of surrogacy practice in many countries, an increase in the number of single parents as well as homosexual couples, and women becoming health conscious are some of the prominent drivers that are boosting the demand for surrogacy tourism all over the globe.
The Challenges and Constraints Confronting the Global Market
The challenges that hinder surrogacy tourism to an extent are less awareness or unclear information about the surrogacy concept and the entire surrogacy tourism exercise.
Moreover, in many regions, surrogacy is an illegal act and banned – countries including Thailand, India, and many others.
The mindset of many couples to have their baby and reliability issues are the other factor that has hampered surrogacy tourism. Other challenges, such as adoption, treatment, and financial, administrative, or practical issues of the service receiver, hinder surrogacy tourism.
Many developing regions such as Asia, the Middle East, and Africa consider single parents and homosexual marriage a taboo; hence due to society's bondage and hesitation, many do not go for practicing surrogacy.
| Attribute | Details |
|---|---|
| Market CAGR (2023 to 2033) | 6.1% |
| Market Valuation (2023) | US$ 258.8 million |
| Market Valuation (2033) | US$ 468.9 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
This process requires great patience, medical and legal knowledge, and a robust support system.
Surrogates have the opportunity to help needy families while also being compensated for their efforts. Ultimately, everyone benefits the intended parents, the surrogate, and any other related person or entity.
Many economic destinations offer surrogacy at a low cost while still providing access to the world's best medical facilities and ART quality. Surrogacy services are available at a meager cost in Kenya, a country that has recently emerged as a favorable hub for fertility tourism.
Surrogacy is a practice in which one woman accepts to abide by pregnancy to grant the newborn baby from that pregnancy to another couple or person, with the mentality that the couple or person would be parent that child.
Technological improvements in aided surrogate technologies, increased awareness regarding infertility treatment, and the development of several fertility clinics drive the growth of the surrogacy tourism market during the forecast period. However, high costs related to the procedure and stringent regulations about surrogacy in several countries restrict the opportunities for surrogacy tourism.
Various factors that lead to infertility include the problem with sperm or egg production, age, genetic factors, and unnecessary exposure to some chemicals and contaminants. Alcohol consumption, steroid use, surgical removal of one of the testicles due to cancer, and diabetes can also result in low sperm count, thereby leading to infertility problems in men, boosting the demand for surrogacy and demand for surrogacy tourism on the whole.
Hormonal disorders, benign uterine growths, abnormal anatomy of the cervix or uterus, blocked fallopian tubes, stress, chemotherapy, kidney, or sickle cell disease can all cause infertility in women, resulting in an increasing trend in demand for surrogacy and demand for surrogacy tourism in general.
The rise in several fertility clinics, along with growth in awareness about fertility treatments such as sperm/egg donation and in-vitro fertilization, escalates the adoption of fertility treatments, thereby propelling the surrogacy tourism market growth.
Moreover, the rise in the prevalence of polycystic ovarian syndrome in women leads to difficulty conceiving a child, resulting in escalated demand for surrogate mothers, thereby expanding surrogacy tourism. However, stringent regulations about commercial methods and the high cost involved in the procedure hamper the global market growth.
Principal Consultant
Technological advancements have played an important role in the market.
The traditional segment of the global market was worth more than US$ 220 million. Traditional surrogacy involves fewer medical procedures and is less expensive than other ART treatments. Traditional surrogacy, on the other hand, carries a higher emotional and legal risk than gestational surrogacy.
Moreover, surrogacy professionals' high adoption of gestational techniques and technological advancements are expected to drive segment growth and surge the surrogacy tourism market. Furthermore, the emotional and legal complexity associated with traditional surrogacy further propels the adoption of gestational surrogacy and the adoption of surrogacy tourism on the whole.
IVF (with ICSI) is considered the safest and best method used for surrogacy.
By technology, the IVF (with ICSI) segment accounted a maximum share in the global market. This segment is expected to exhibit a prominent growth rate, attributed to the fact that it has revolutionized male infertility treatment, as it requires a smaller number of sperm that are penetrated eggs with the help of an injection technique.
Women aged between 26-35 are usually preferred for surrogacy.
The surrogacy process is quite delicate and complex, so the entire process should be carried out with utmost care. It includes the person going through it, i.e., women. As the age grows, the risk factors also increase, which can lead to unwanted consequences like causing harm to both the woman and the fetus inside.
Hence, the age factor is one of the essential elements to be taken care of during the surrogacy process, influencing the surrogacy tourism market's key trends and opportunities.
The presence of sophisticated facilities and equipment for advanced infertility treatments in hospitals to drive segment growth.
The hospital segment of the market was worth more than US$ 1 billion in 2020, owing to an increase in the number of hospitals offering surrogacy treatment and the availability of advanced facilities.
Furthermore, rising healthcare investment and the availability of advanced equipment in hospitals drive the global market. As a result, a positive outcome and the presence of qualified clinical staff for surrogacy treatment in the hospital drive the market.
North America is Expected to Dominate the Global Surrogacy Market
North America is expected to dominate the market due to increased gestational surrogacy, increasing fertility centers, and technological advancements in this region.
For instance, according to the American Society for Reproductive Medicine (ASRM), gestational carrier cycles resulted in more than 75% of infants born. The market share held by the North American market is 26%.
In North American countries, surrogacy is expensive, ranging from around US$ 120,000 to US$ 200,000, especially in the United States.
Europe has the higher share in the global market of approximately 40%.
Surrogacy is recognized under section 30 of the Human Fertilization and Embryology Act 2008; In May 2016, a ruling by the Family Division of the High Court of Justice for England and Wales determined that single people can apply to be recognized as the legal parents of a child following a surrogacy arrangement.
In December 2018, allow applications from individuals subject to conditions, including genetic relation to the child. Singles, as well as homosexuals seeking parenthood, may use it as well, provided that they are United Kingdom residents. The 1985 Surrogacy Arrangements Act prohibits surrogacy-related commercial arrangements.
Apart from the United Kingdom, other major European countries like France, Germany, Spain, and Italy have banned the concept of surrogacy and don't encourage it, hampering the market opportunities.
Due to the low cost of surrogacy treatment and the significant rise in reproductive tourism, the Asia Pacific market captured more than 28% of the revenue share. Furthermore, healthcare facilities for providing fertility treatments are expanding in developing countries.
Thus, low treatment costs, top medical professionals' availability, and favorable surrogacy treatment regulations are influencing regional market growth along with key trends and opportunities.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The competitive landscape of the market has also been examined along with the profiles of the key players like IV Marbella (Spain), Istanbul Fertility and Women's Health Center (Turkey), Intersono IVF Clinic (Ukraine), Embryolab (Greece), GEST (Praga Medica) (Czech Republic), Smart Choice Medical Travel (Hungary), Ava-Peter Clinic (Russia), Nadezhda Fertility Clinic (Bulgaria) and Medicover Fertility (India) among many others.
Recent Developments in the Global Market are:
In 2021, Triangle Capital Corporation announced its acquisition of Bourn Hall Ltd., a British fertility clinic—the purchase to help the company enhance its reach to its customers and offer business expansion opportunities.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Product Type, Mode of Prescription, Sales Channel, Region |
| Key Companies Profiled | IV Marbella (Spain); Istanbul Fertility and Women’s Health Center (Turkey); Intersono IVF Clinic (Ukraine); Embryolab (Greece); GEST (Praga Medica) (Czech Republic); Smart Choice Medical Travel (Hungary); Ava-Peter Clinic (Russia); Nadezhda Fertility Clinic (Bulgaria) and Medicover Fertility (India) |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is expected to secure a valuation of US$ 258.8 million in 2023.
The growth potential of the surrogacy tourism market is 6.1% through 2033.
IV Marbella (Spain), and Istanbul Fertility & Women’s Health Center are the essential market players.
The traditional segment is likely to remain preferred through 2033.
The market is estimated to reach US$ 468.9 million by 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Gestational surrogacy
5.3.2. Traditional surrogacy
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Tour Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Tour Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Tour Type, 2023 to 2033
6.3.1. Domestic
6.3.2. International
6.4. Y-o-Y Growth Trend Analysis By Tour Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Tour Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis by Technology, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by Technology, 2023 to 2033
7.3.1. IVF with ICSI
7.3.2. IVF without ICSI
7.3.3. Intrauterine Insemination
7.4. Y-o-Y Growth Trend Analysis by Technology, 2018 to 2022
7.5. Absolute $ Opportunity Analysis by Technology, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Service Provider
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Service Provider, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Provider, 2023 to 2033
8.3.1. Hospitals
8.3.2. Fertility Clinics
8.4. Y-o-Y Growth Trend Analysis By Service Provider, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By Service Provider, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Age Group
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By Age Group, 2018 to 2022
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Age Group, 2023 to 2033
9.3.1. 26-35 Years
9.3.2. 36-45 Years
9.3.3. 46-55 Years
9.4. Y-o-Y Growth Trend Analysis By Age Group, 2018 to 2022
9.5. Absolute $ Opportunity Analysis By Age Group, 2023 to 2033
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. South Asia and Pacific
10.3.6. East Asia
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. The USA
11.2.1.2. Canada
11.2.2. By Type
11.2.3. By Tour Type
11.2.4. By Technology
11.2.5. By Service Provider
11.2.6. By Age Group
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Tour Type
11.3.4. By Technology
11.3.5. By Service Provider
11.3.6. By Age Group
11.4. Key Takeaways
12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Type
12.2.3. By Tour Type
12.2.4. By Technology
12.2.5. By Service Provider
12.2.6. By Age Group
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Tour Type
12.3.4. By Technology
12.3.5. By Service Provider
12.3.6. By Age Group
12.4. Key Takeaways
13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. United Kingdom
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Type
13.2.3. By Tour Type
13.2.4. By Technology
13.2.5. By Service Provider
13.2.6. By Age Group
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Tour Type
13.3.4. By Technology
13.3.5. By Service Provider
13.3.6. By Age Group
13.4. Key Takeaways
14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Poland
14.2.1.2. Russia
14.2.1.3. Czech Republic
14.2.1.4. Romania
14.2.1.5. Rest of Eastern Europe
14.2.2. By Type
14.2.3. By Tour Type
14.2.4. By Technology
14.2.5. By Service Provider
14.2.6. By Age Group
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Tour Type
14.3.4. By Technology
14.3.5. By Service Provider
14.3.6. By Age Group
14.4. Key Takeaways
15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Bangladesh
15.2.1.3. Australia
15.2.1.4. New Zealand
15.2.1.5. Rest of South Asia and Pacific
15.2.2. By Type
15.2.3. By Tour Type
15.2.4. By Technology
15.2.5. By Service Provider
15.2.6. By Age Group
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type
15.3.3. By Tour Type
15.3.4. By Technology
15.3.5. By Service Provider
15.3.6. By Age Group
15.4. Key Takeaways
16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. China
16.2.1.2. Japan
16.2.1.3. South Korea
16.2.2. By Type
16.2.3. By Tour Type
16.2.4. By Technology
16.2.5. By Service Provider
16.2.6. By Age Group
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Type
16.3.3. By Tour Type
16.3.4. By Technology
16.3.5. By Service Provider
16.3.6. By Age Group
16.4. Key Takeaways
17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Israel
17.2.1.4. Rest of MEA
17.2.2. By Type
17.2.3. By Tour Type
17.2.4. By Technology
17.2.5. By Service Provider
17.2.6. By Age Group
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Type
17.3.3. By Tour Type
17.3.4. By Technology
17.3.5. By Service Provider
17.3.6. By Age Group
17.4. Key Takeaways
18. Key Countries Market Analysis
18.1. USA
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2022
18.1.2.1. By Type
18.1.2.2. By Tour Type
18.1.2.3. By Technology
18.1.2.4. By Service Provider
18.1.2.5. By Age Group
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2022
18.2.2.1. By Type
18.2.2.2. By Tour Type
18.2.2.3. By Technology
18.2.2.4. By Service Provider
18.2.2.5. By Age Group
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2022
18.3.2.1. By Type
18.3.2.2. By Tour Type
18.3.2.3. By Technology
18.3.2.4. By Service Provider
18.3.2.5. By Age Group
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2022
18.4.2.1. By Type
18.4.2.2. By Tour Type
18.4.2.3. By Technology
18.4.2.4. By Service Provider
18.4.2.5. By Age Group
18.5. Germany
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2022
18.5.2.1. By Type
18.5.2.2. By Tour Type
18.5.2.3. By Technology
18.5.2.4. By Service Provider
18.5.2.5. By Age Group
18.6. United Kingdom
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2022
18.6.2.1. By Type
18.6.2.2. By Tour Type
18.6.2.3. By Technology
18.6.2.4. By Service Provider
18.6.2.5. By Age Group
18.7. France
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2022
18.7.2.1. By Type
18.7.2.2. By Tour Type
18.7.2.3. By Technology
18.7.2.4. By Service Provider
18.7.2.5. By Age Group
18.8. Spain
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2022
18.8.2.1. By Type
18.8.2.2. By Tour Type
18.8.2.3. By Technology
18.8.2.4. By Service Provider
18.8.2.5. By Age Group
18.9. Italy
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2022
18.9.2.1. By Type
18.9.2.2. By Tour Type
18.9.2.3. By Technology
18.9.2.4. By Service Provider
18.9.2.5. By Age Group
18.10. Poland
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2022
18.10.2.1. By Type
18.10.2.2. By Tour Type
18.10.2.3. By Technology
18.10.2.4. By Service Provider
18.10.2.5. By Age Group
18.11. Russia
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2022
18.11.2.1. By Type
18.11.2.2. By Tour Type
18.11.2.3. By Technology
18.11.2.4. By Service Provider
18.11.2.5. By Age Group
18.12. Czech Republic
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2022
18.12.2.1. By Type
18.12.2.2. By Tour Type
18.12.2.3. By Technology
18.12.2.4. By Service Provider
18.12.2.5. By Age Group
18.13. Romania
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2022
18.13.2.1. By Type
18.13.2.2. By Tour Type
18.13.2.3. By Technology
18.13.2.4. By Service Provider
18.13.2.5. By Age Group
18.14. India
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2022
18.14.2.1. By Type
18.14.2.2. By Tour Type
18.14.2.3. By Technology
18.14.2.4. By Service Provider
18.14.2.5. By Age Group
18.15. Bangladesh
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2022
18.15.2.1. By Type
18.15.2.2. By Tour Type
18.15.2.3. By Technology
18.15.2.4. By Service Provider
18.15.2.5. By Age Group
18.16. Australia
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2022
18.16.2.1. By Type
18.16.2.2. By Tour Type
18.16.2.3. By Technology
18.16.2.4. By Service Provider
18.16.2.5. By Age Group
18.17. New Zealand
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2022
18.17.2.1. By Type
18.17.2.2. By Tour Type
18.17.2.3. By Technology
18.17.2.4. By Service Provider
18.17.2.5. By Age Group
18.18. China
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2022
18.18.2.1. By Type
18.18.2.2. By Tour Type
18.18.2.3. By Technology
18.18.2.4. By Service Provider
18.18.2.5. By Age Group
18.19. Japan
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2022
18.19.2.1. By Type
18.19.2.2. By Tour Type
18.19.2.3. By Technology
18.19.2.4. By Service Provider
18.19.2.5. By Age Group
18.20. South Korea
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2022
18.20.2.1. By Type
18.20.2.2. By Tour Type
18.20.2.3. By Technology
18.20.2.4. By Service Provider
18.20.2.5. By Age Group
18.21. GCC Countries
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2022
18.21.2.1. By Type
18.21.2.2. By Tour Type
18.21.2.3. By Technology
18.21.2.4. By Service Provider
18.21.2.5. By Age Group
18.22. South Africa
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2022
18.22.2.1. By Type
18.22.2.2. By Tour Type
18.22.2.3. By Technology
18.22.2.4. By Service Provider
18.22.2.5. By Age Group
18.23. Israel
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2022
18.23.2.1. By Type
18.23.2.2. By Tour Type
18.23.2.3. By Technology
18.23.2.4. By Service Provider
18.23.2.5. By Age Group
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Type
19.3.3. By Tour Type
19.3.4. By Technology
19.3.5. By Service Provider
19.3.6. By Age Group
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. Istanbul Fertility and Women’s Health Center
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.2. Intersono IVF Clinic
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.3. Embryolab
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.4. GEST (Praga Medica)
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.5. IV Marbella
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.6. Smart Choice Medical Travel
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.7. Ava-Peter Clinic
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.8. Nadezhda Fertility Clinic
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.9. Medicover Fertility
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.10. Circle Surrogacy
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
20.1.11. Clinic Scanfert
20.1.11.1. Overview
20.1.11.2. Product Portfolio
20.1.11.3. Profitability by Market Segments
20.1.11.4. Sales Footprint
20.1.11.5. Strategy Overview
20.1.11.5.1. Marketing Strategy
20.1.12. IVIRMA
20.1.12.1. Overview
20.1.12.2. Product Portfolio
20.1.12.3. Profitability by Market Segments
20.1.12.4. Sales Footprint
20.1.12.5. Strategy Overview
20.1.12.5.1. Marketing Strategy
20.1.13. NOVA
20.1.13.1. Overview
20.1.13.2. Product Portfolio
20.1.13.3. Profitability by Market Segments
20.1.13.4. Sales Footprint
20.1.13.5. Strategy Overview
20.1.13.5.1. Marketing Strategy
20.1.14. Bnagkok IVF Centre
20.1.14.1. Overview
20.1.14.2. Product Portfolio
20.1.14.3. Profitability by Market Segments
20.1.14.4. Sales Footprint
20.1.14.5. Strategy Overview
20.1.14.5.1. Marketing Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
Explore Travel and Tourism Insights
View Reports
Surrogacy Tourism Market
